If you made any changes in Pure these will be visible here soon.

Research Output 1989 2019

2019

Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levels

Nicoll, A. J., Roberts, S. K., Lim, R., Mitchell, J., Weltman, M., George, J., Wigg, A., Stuart, K., Gow, P., MacQuillan, G., Tse, E., Levy, M., Sood, S., Zekry, A., Cheng, W., Mitchell, J., Skoien, R., Sievert, W., Strasser, S. I., McCaughan, G. W. & 1 others, on behalf of the ALA Clinical Research Network, Gastroenterological Society of Australia, 1 May 2019, In : Alimentary Pharmacology and Therapeutics. 49, 10, p. 1314-1322 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Human amnion epithelial cells and their soluble factors reduce liver fibrosis in murine non-alcoholic steatohepatitis

Kuk, N., Hodge, A., Sun, Y., Correia, J., Alhomrani, M., Samuel, C., Moore, G., Lim, R. & Sievert, W., Aug 2019, In : Journal of Gastroenterology and Hepatology. 34, 8, p. 1441-1449 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Impact of preexisting hepatitis C virus genotype 6 NS3, NS5A, and NS5B polymorphisms on the in vitro potency of direct-acting antiviral agents

McPhee, F., Ueland, J., Vellucci, V., Bowden, S., Sievert, W. & Zhou, N., 1 Apr 2019, In : Antimicrobial Agents and Chemotherapy. 63, 4, 12 p., e02205-18.

Research output: Contribution to journalArticleResearchpeer-review

2018

Amnion Epithelial Cell-Derived Exosomes Restrict Lung Injury and Enhance Endogenous Lung Repair

Tan, J. L., Lau, S. N., Leaw, B., Nguyen, H. P. T., Salamonsen, L. A., Saad, M. I., Chan, S. T., Zhu, D., Krause, M., Kim, C., Sievert, W., Wallace, E. M. & Lim, R., 1 Feb 2018, In : Stem Cells Translational Medicine. 7, 2, p. 180-196 17 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy

Roberts, S. K., Lim, R., Strasser, S., Nicoll, A., Gazzola, A., Mitchell, J., Siow, W., Khoo, T., Hamarneh, Z., Weltman, M., Gow, P., Janko, N., Tse, E., Mishra, G., Cheng, E. H., Levy, M., Cheng, W., Sood, S., Skoien, R., Mitchell, J. & 8 others, Zekry, A., George, J., MacQuillan, G., Wigg, A., Stuart, K., Sievert, W., McCaughan, G. & ALA Clinical Research Network, 1 Feb 2018, In : Clinical Gastroenterology and Hepatology. 16, 2, p. 268-277 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Hyperactive gp130/STAT3-driven gastric tumourigenesis promotes submucosal tertiary lymphoid structure development

Hill, D. G., Yu, L., Gao, H., Balic, J. J., West, A., Oshima, H., McLeod, L., Oshima, M., Gallimore, A., D'Costa, K., Bhathal, P. S., Sievert, W., Ferrero, R. L., Jenkins, B. J. & Jones, G. W., 1 Jul 2018, In : International Journal of Cancer. 143, 1, p. 167-178 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
2017

Adenosine triphosphate bioluminescence to validate decontamination of endoscopes

Gillespie, E., Sievert, W., Swan, M., Kaye, C., Edridge, I. & Stuart, R. L., 1 Dec 2017, In : Journal of Hospital Infection. 97, 4, p. 353-356 4 p.

Research output: Contribution to journalArticleResearchpeer-review

Antenatal maternal hepatitis B care is a predictor of timely perinatal administration of hepatitis B immunoglobulin

Le, S. T. T., Sahhar, L., Spring, S., Sievert, W. & Dev, A. T., 1 Aug 2017, In : Internal Medicine Journal. 47, 8, p. 915-922 8 p.

Research output: Contribution to journalArticleResearchpeer-review

A pilot study evaluating the safety of intravenously administered human amnion epithelial cells for the treatment of hepatic fibrosis

Lim, R., Hodge, A., Moore, G., Wallace, E. M. & Sievert, W., 23 Aug 2017, In : Frontiers in Pharmacology. 8, AUG, 9 p., 549.

Research output: Contribution to journalArticleOtherpeer-review

Open Access
File

Cell-based therapies for tissue fibrosis

Lim, R., Ricardo, S. D. & Sievert, W., 22 Sep 2017, In : Frontiers in Pharmacology. 8, 8 p., 633.

Research output: Contribution to journalReview ArticleResearchpeer-review

Open Access
File

Cell Therapy in Chronic Liver Disease

Alhomrani, M., Lim, R. & Sievert, W., 2017, Liver, Lung and Heart Regeneration. Pham, P. V. (ed.). Cham Switzerland: Springer, p. 151-39 25 p. (Stem Cells in Clinical Applications).

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Otherpeer-review

Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment

Hajarizadeh, B., Grebely, J., McManus, H., Estes, C., Razavi, H., Gray, R. T., Alavi, M., Amin, J., McGregor, S., Sievert, W., Thompson, A. & Dore, G. J., 1 Jan 2017, In : Journal of Gastroenterology and Hepatology. 32, 1, p. 229-236 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Coffee intake is associated with a lower liver stiffness in patients with non-alcoholic fatty liver disease, hepatitis C, and hepatitis B

Hodge, A., Lim, S., Goh, E., Wong, O., Marsh, P., Knight, V., Sievert, W. & de Courten, B., 10 Jan 2017, In : Nutrients. 9, 1, 9 p., 56.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Cytoplasmic domain of tissue factor promotes liver fibrosis in mice

Knight, V., Lourensz, D., Tchongue, J., Correia, J., Tipping, P. & Sievert, W., 21 Aug 2017, In : World Journal of Gastroenterology. 23, 31, p. 5692-5699 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Five-year efficacy and safety of tenofovir-based salvage therapy for patients with chronic hepatitis B who previously failed LAM/ADV therapy

Lim, L., Thompson, A., Patterson, S., George, J., Strasser, S., Lee, A., Sievert, W., Nicoll, A., Desmond, P., Roberts, S., Marion, K., Bowden, S., Locarnini, S. & Angus, P., Jun 2017, In : Liver International. 37, 6, p. 827-835 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

The Polaris Observatory HCV Collaborators, 1 Mar 2017, In : The Lancet Gastroenterology and Hepatology. 2, 3, p. 161-176 16 p.

Research output: Contribution to journalArticleResearchpeer-review

Interferon alpha

Grebely, J., Dore, G. & Sievert, W., 2 Oct 2017, Kucers the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition. Grayson, M. L. (ed.). Boca Raton FL USA: CRC Press, p. 4409-4431 23 p.

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Otherpeer-review

Interferon-free treatment for HCV infection: are we on the road to elimination?

Sievert, W., 1 Mar 2017, In : Internal Medicine Journal. 47, 3, p. 247-249 3 p.

Research output: Contribution to journalEditorialOtherpeer-review

The human amnion epithelial cell secretome decreases hepatic fibrosis in mice with chronic liver fibrosis

Alhomrani, M., Correia, J., Zavou, M., Leaw, B., Kuk, N., Xu, R., Saad, M. I., Hodge, A., Greening, D. W., Lim, R. & Sievert, W., 24 Oct 2017, In : Frontiers in Pharmacology. 8, OCT, 13 p., 748.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
2016

Could Adherence to Quality of Care Indicators for Hospitalized Patients with Cirrhosis-Related Ascites Improve Clinical Outcomes?

Le, S., Spelman, T., Chong, C-P., Ha, P., Sahhar, L., Lim, J., He, T., Heerasing, N. & Sievert, W., 1 Jan 2016, In : American Journal of Gastroenterology. 111, 1, p. 87-92 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: A pooled analysis

Kao, J-H., Jensen, D. M., Manns, M. P., Jacobson, I., Kumada, H., Toyota, J., Heo, J., Yoffe, B., Sievert, W., Bessone, F., Peng, C-Y., Roberts, S. K., Lee, Y-J., Bhore, R., Mendez, P., Hughes, E. & Noviello, S., 2016, In : Liver International. 36, 7, p. 954-962 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Quality of life and social functioning during treatment of recent hepatitis C infection: A multi-centre prospective cohort

Doyle, J. S., Grebely, J., Spelman, T., Alavi, M., Matthews, G. V., Thompson, A. J., Dore, G. J., Hellard, M. E. & the ATAHC Study Group, 29 Jun 2016, In : PLoS ONE. 11, 6, 16 p., e0150655.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

The use of placenta-derived cells in inflammatory and fibrotic disorders

Wallace, E. M., Cargnoni, A., Lim, R., Hodge, A. & Sievert, W., 22 Feb 2016, Placenta: The Tree of Life. Parolini, O. (ed.). Boca Raton FL USA: CRC Press, p. 181-196 16 p. (Gene and Cell Therapy).

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Otherpeer-review

USING ADENOSINETRIPHOSPHATE BIOLUMINESCENCE TO VALIDATE DECONTAMINATION FOR DUODENOSCOPES

Gillespie, E., Sievert, W., Swan, M., Kaye, C., Edridge, I. & Stuart, R. L., 1 Oct 2016, In : Australian Nursing and Midwifery Journal. 24, 4, p. 26-28 3 p.

Research output: Contribution to journalArticleResearchpeer-review

2015

A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan

Bennett, H., Waser, N., Johnston, K., Kao, J-H., Lim, Y-S., Duan, Z., Lee, Y-J., Wei, L., Chen, C-J., Sievert, W., Yuan, Y. & Li, H., 2015, In : Hepatology International. 9, 3, p. 378 - 390 13 p.

Research output: Contribution to journalArticleResearchpeer-review

Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: A randomised study

Hezode, C., Hirschfield, G. M., Ghesquiere, W. G., Sievert, W., Rodriguez-Torres, M., Shafran, S. D., Thuluvath, P. J., Tatum, H. A., Waked, I. A., Esmat, G., Lawitz, E., Rustgi, V. K., Pol, S. B., Weis, N., Pockros, P. J., Bourliere, M., Serfaty, L., Vierling, J. M., Fried, M. W., Weiland, O. & 14 others, Brunetto, M. R., Everson, G. T., Zeuzem, S., Kwo, P. Y., Sulkowski, M. S., Brau, N., Hernandez, D., McPhee, F., Wind-Rotolo, M., Liu, Z., Noviello, S., Hughes, E. A., Yin, P. D. & Schnittman, S., 2015, In : Gut. 64, 6, p. 948-956 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with prev

Lawitz, E., Gane, E. J., Pearlman, B., Tam, E., Ghesquiere, W., Guyader, D., Alric, L., Bronowicki, J-P., Lester, L., Sievert, W., Ghalib, R., Balart, L., Sund, F., Lagging, M., Dutko, F., Shaughnessy, M., Hwang, P., Howe, A. Y. M., Wahl, J., Robertson, M. N. & 2 others, Barr, E. & Haber, B., 2015, In : The Lancet. 385, 9973, p. 1075 - 1086 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection

Poordad, F., Sievert, W., Mollison, L., Bennett, M., Tse, E., Brau, N., Levin, J. M., Sepe, T. E., Lee, S. S., Angus, P. W., Conway, B., Pol, S. B., Boyer, N., Bronowicki, J-P., Jacobson, I. M., Muir, A. J., Reddy, K. R., Tam, E., Ortiz-Lasanta, G., de Ledinghen, V. & 6 others, Sulkowski, M. S., Boparai, N., McPhee, F., Hughes, E. A., Swenson, E. S. & Yin, P. D., 2015, In : JAMA. 313, 17, p. 1728 - 1735 8 p.

Research output: Contribution to journalArticleResearchpeer-review

HCV-infected patients need access now to new direct-acting antiviral agents to avert liver-related deaths

Sievert, W., 2015, In : Medical Journal of Australia. 202, 9, p. 479 - 479 1 p.

Research output: Contribution to journalLetterOther

The relationships between IFNL4 genotype, intrahepatic interferon-stimulated gene expression and interferon treatment response differs in HCV-1 compared with HCV-3

Holmes, J. A., Congiu, M., Bonanzinga, S., Sandhu, M. K., Kia, Y. H., Bell, S. J., Nguyen, T., Iser, D. M., Visvanathan, K., Sievert, W., Bowden, D. S., Desmond, P. V. & Thompson, A. J. V., 2015, In : Alimentary Pharmacology and Therapeutics. 42, 3, p. 296 - 306 11 p.

Research output: Contribution to journalArticleResearchpeer-review

2014

All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study

Manns, M. P., Pol, S. B., Jacobson, I. M., Marcellin, P. M., Gordon, S. C., Peng, C-Y., Chang, T-T., Everson, G. T., Heo, J., Gerken, G., Yoffe, B., Towner, W. J., Bourliere, M., Metivier, S., Chu, C-J., Sievert, W., Bronowicki, J-P., Thabut, D., Lee, Y-J., Kao, J-H. & 6 others, McPhee, F., Kopit, J., Mendez, P., Linaberry, M., Hughes, E. A. & Noviello, S., 2014, In : The Lancet. 384, 9954, p. 1597 - 1605 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: analysis from the PREDICT and CHARIOT studies

Roberts, S. K., Mitchell, J., Leung, R., Booth, D., Bollipo, S., Ostapowicz, G., Sloss, A., McCaughan, G., Dore, G. J., Thompson, A. J. V., Crawford, D., Sievert, W., Weltman, M. D., Cheng, W. & George, J., 2014, In : Journal of Gastroenterology and Hepatology. 29, 1, p. 179 - 184 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia

Sievert, W., Razavi, H. A., Estes, C., Thompson, A. J. V., Zekry, A., Roberts, S. K. & Dore, G. J., 2014, In : Journal of Gastroenterology and Hepatology. 29, Suppl 1, p. 1 - 9 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Hepatocellular carcinoma in Australia's Northern Territory: high incidence and poor outcome

Parker, C., Tong, S. Y. C., Dempsey, K., Condon, J., Sharma, S. K., Chen, J. W. C., Sievert, W. & Davis, J. S., 2014, In : Medical Journal of Australia. 201, 8, p. 470 - 474 5 p.

Research output: Contribution to journalArticleResearchpeer-review

Historical epidemiology of hepatitis C virus (HCV) in selected countries

Bruggmann, P., Berg, T., Ovrehus, A. L. H., Moreno, C. A., Brandao-Mello, C. E., Roudot-Thoraval, F., Marinho, R. T., Sherman, M., Ryder, S. D., Sperl, J., Akarca, U. S., Balik, I., Bihl, F. K., Bilodeau, M., Blasco, A. J., Buti, M. A., Calinas, F., Calleja, J. L., Cheinquer, H., Christensen, P. B. & 73 others, Clausen, M., Coelho, H. S. M., Cornberg, M., Cramp, M. E., Dore, G. J., Doss, W. H., Duberg, A. S., El-Sayed, M. H., Ergor, G., Esmat, G., Estes, C., Falconer, K., Felix, J., Ferraz, M. L. G., Ferreira, P. R., Frankova, S., Garcia-Samaniego, J., Gerstoft, J., Giria, J. A., Goncales, F. L., Gower, E. E., Gschwantler, M., Guimaraes Pessoa, M., Hezode, C., Hofer, H., Husa, P., Idilman, R., Kaberg, M., Kaita, K., Kautz, A., Kaymakoglu, S., Krajden, M., Krarup, H., Laleman, W. J., Lavanchy, D., Lazaro, P., Marotta, P., Mauss, S., Mendes-Correa, M. C. J., Mullhaupt, B., Myers, R. P., Negro, F., Nemecek, V., Ormeci, N., Parkes, J., Peltekian, K. M., Ramji, A. S., Razavi, H. A., Reis, N., Roberts, S. K., Rosenberg, W. M. C., Sarmento-Castro, R., Sarrazin, C. M., Semela, D., Shiha, G. E., Sievert, W., Starkel, P., Stauber, R. E., Thompson, A. J. V., Urbanek, P., Van Thiel, I., Van Vlierberghe, H., Vandijck, D. M., Vogel, W., Waked, I. A., Wedemeyer, H., Weis, N., Wiegand, J., Yosry, A., Zekry, A., Van Damme, P., Aleman, S. & Hindman, S. J., 2014, In : Journal of Viral Hepatitis. 21, Supplement S1, p. 5 - 33 29 p.

Research output: Contribution to journalArticleResearchpeer-review

Interleukin-28B rs12979860 C allele: protective against advanced fibrosis in chronic hepatitis C genotype 1 infection

Kitson, M. T., George, J., Dore, G. J., Leung, R., Button, P., McCaughan, G., Crawford, D., Sievert, W., Weltman, M. D., Cheng, W. & Roberts, S. K., 2014, In : Journal of Gastroenterology and Hepatology. 29, 7, p. 1458 - 1462 5 p.

Research output: Contribution to journalArticleResearchpeer-review

ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological response

Holmes, J. A., Roberts, S. K., Ali, R. J., Dore, G. J., Sievert, W., McCaughan, G., Crawford, D., Cheng, W., Weltman, M. D., Bonanzinga, S., Visvanathan, K., Sundararajan, V., Desmond, P. V., Bowden, D. S., Matthews, G. V. & Thompson, A., 2014, In : Hepatology. 59, 6, p. 2152 - 2160 9 p.

Research output: Contribution to journalArticleResearchpeer-review

RE: Investigating iron deficiency anaemia

Sievert, W., Leggett, B. A. & Macrae, F. A., Jan 2014, In : Medical Journal of Australia. 200, 1, p. 18-20 3 p.

Research output: Contribution to journalLetterOtherpeer-review

Soluble factors derived from human amniotic epithelial cells suppress collagen production in human hepatic stellate cells

Hodge, A., Lourensz, D., Vaghjiani, V., Nguyen, K. H., Tchongue, J., Wang, B., Murthi, P., Sievert, W. & Manuelpillai, U. C., 2014, In : Cytotherapy. 16, 8, p. 1132 - 1144 13 p.

Research output: Contribution to journalArticleResearchpeer-review

Strategies to manage hepatitis C virus (HCV) disease burden

Wedemeyer, H., Duberg, A. S., Buti, M. A., Rosenberg, W. M. C., Frankova, S., Esmat, G., Ormeci, N., Van Vlierberghe, H., Gschwantler, M., Akarca, U. S., Aleman, S., Balik, I., Berg, T., Bihl, F. K., Bilodeau, M., Blasco, A. J., Brandao-Mello, C. E., Bruggmann, P., Calinas, F., Calleja, J. L. & 73 others, Cheinquer, H., Christensen, P. B., Clausen, M., Coelho, H. S. M., Cornberg, M., Cramp, M. E., Dore, G. J., Doss, W. H., El-Sayed, M. H., Ergor, G., Estes, C., Falconer, K., Felix, J., Ferraz, M. L. G., Ferreira, P. R., Garcia-Samaniego, J., Gerstoft, J., Giria, J. A., Goncales, F. L., Guimaraes Pessoa, M., Hezode, C., Hindman, S. J., Hofer, H., Husa, P., Idilman, R., Kaberg, M., Kaita, K., Kautz, A., Kaymakoglu, S., Krajden, M., Krarup, H., Laleman, W. J., Lavanchy, D., Lazaro, P., Marinho, R. T., Marotta, P., Mauss, S., Mendes-Correa, M. C. J., Moreno, C. A., Mullhaupt, B., Myers, R. P., Nemecek, V., Ovrehus, A. L. H., Parkes, J., Peltekian, K. M., Ramji, A. S., Razavi, H. A., Reis, N., Roberts, S. K., Roudot-Thoraval, F., Ryder, S. D., Sarmento-Castro, R., Sarrazin, C. M., Semela, D., Sherman, M., Shiha, G. E., Sperl, J., Starkel, P., Stauber, R. E., Thompson, A. J. V., Urbanek, P., Van Damme, P., Van Thiel, I., Vandijck, D. M., Vogel, W., Waked, I. A., Weis, N., Wiegand, J., Yosry, A., Zekry, A., Negro, F., Sievert, W. & Gower, E. E., 2014, In : Journal of Viral Hepatitis. 21, Supplement S1, p. 60 - 89 30 p.

Research output: Contribution to journalArticleResearchpeer-review

Telaprevir twice daily is noninferior to telaprevir every 8 hours for patients with chronic hepatitis C

Buti, M., Agarwal, K., Horsmans, Y., Sievert, W., Janczewska, E., Zeuzem, S., Nyberg, L. M., Brown Jr, R. S., Hezode, C., Rizzetto, M., Parana, R., De Meyer, S., De Masi, R. J., Luo, D., Bertelsen, K. & Witek, J., 2014, In : Gastroenterology. 146, 3, p. 744 - 753 e3 10 p.

Research output: Contribution to journalArticleResearchpeer-review

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

Razavi, H. A., Waked, I. A., Sarrazin, C. M., Myers, R. P., Idilman, R., Calinas, F., Vogel, W., Mendes-Correa, M. C. J., Hezode, C., Lazaro, P., Akarca, U. S., Aleman, S., Balik, I., Berg, T., Bihl, F. K., Bilodeau, M., Blasco, A. J., Brandao-Mello, C. E., Bruggmann, P., Buti, M. A. & 75 others, Calleja, J. L., Cheinquer, H., Christensen, P. B., Clausen, M., Coelho, H. S. M., Cramp, M. E., Dore, G. J., Doss, W. H., Duberg, A. S., El-Sayed, M. H., Ergor, G., Esmat, G., Falconer, K., Felix, J., Ferraz, M. L. G., Ferreira, P. R., Frankova, S., Garcia-Samaniego, J., Gerstoft, J., Giria, J. A., Goncales, F. L., Gower, E. E., Gschwantler, M., Guimaraes Pessoa, M., Hindman, S. J., Hofer, H., Husa, P., Kaberg, M., Kaita, K., Kautz, A., Kaymakoglu, S., Krajden, M., Krarup, H., Laleman, W. J., Lavanchy, D., Marinho, R. T., Marotta, P., Mauss, S., Moreno, C. A., Murphy, K., Negro, F., Nemecek, V., Ormeci, N., Ovrehus, A. L. H., Parkes, J., Pasini, K., Peltekian, K. M., Ramji, A. S., Reis, N., Roberts, S. K., Rosenberg, W. M. C., Roudot-Thoraval, F., Ryder, S. D., Sarmento-Castro, R., Semela, D., Sherman, M., Shiha, G. E., Sievert, W., Sperl, J., Starkel, P., Stauber, R. E., Thompson, A. J. V., Urbanek, P., Van Damme, P., Van Thiel, I., Van Vlierberghe, H., Vandijck, D. M., Wedemeyer, H., Weis, N., Wiegand, J., Yosry, A., Zekry, A., Cornberg, M., Mullhaupt, B. & Estes, C., 2014, In : Journal of Viral Hepatitis. 21, Supplement S1, p. 34 - 59 26 p.

Research output: Contribution to journalArticleResearchpeer-review

2013

Deriving hepatocyte-like cells from placental cells for transplantation

Vaghjiani, V., Vaithilingam, V., Tuch, B., Sievert, W. & Manuelpillai, U. C., 2013, In : Current Stem Cell Research and Therapy. 8, 1, p. 15 - 24 10 p.

Research output: Contribution to journalArticleResearchpeer-review

IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-alpha

Holmes, J., Nguyen, T., Ratnam, D., Heerasing, N. M., Tehan, J. V., Bonanzinga, S., Dev, A. T., Bell, S., Pianko, S., Chen, R., Visvanathan, K., Hammond, R. A., Iser, D., Rusli, F., Sievert, W., Bowden, S. & Thompson, A. J., 2013, In : Journal of Gastroenterology and Hepatology. 28, 5, p. 861 - 866 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Investigating iron deficiency anaemia

Sievert, W., Macrae, F. A. & Leggett, B., 2013, In : Medical Journal of Australia. 198, 10, p. 563 - 563 1 p.

Research output: Contribution to journalArticleOther

Nucleotide oligomerization domain 1 enhances IFN-gamma signaling in gastric epithelial cells during Helicobacter pylori infection and exacerbates disease severity

Allison, C. C., Ferrand, J. F. P., McLeod, L., Hassan, M., Kaparakis-Liaskos, M., Grubman, A., Bhathal, P. S., Dev, A. T., Sievert, W., Jenkins, B. J. & Ferrero, R. L., 2013, In : Journal of Immunology. 190, 7, p. 3706-3715 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

Marcellin, P., Gane, E. J., Buti, M., Afdhal, N. H., Sievert, W., Jacobson, I. M., Washington, M. K., Germanidis, G., Flaherty, J. F., Schall, R. A., Bornstein, J. D., Kitrinos, K. M., Subramanian, G. M., McHutchison, J. G. & Heathcote, E. J., 2013, In : The Lancet. 381, 9865, p. 468 - 475 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection

Kitson, M., Dore, G. J., George, J., McCaughan, G., Crawford, D., Sievert, W., Weltman, M. D., Cheng, W. & Roberts, S. K., 2013, In : Journal of Hepatology. 58, 3, p. 467 - 472 6 p.

Research output: Contribution to journalArticleResearchpeer-review

2012

Cost-effectiveness of truncated therapy for hepatitis C based on rapid virologic response

Gellad, Z. F., Muir, A. J., McHutchison, J. G., Sievert, W., Sharara, A. I., Brown, K. A., Flisiak, R., Jacobson, I. M., Kershenobich, D., Manns, M. P., Schulman, K. & Reed, S. D., 2012, In : Value in Health. 15, 6, p. 876 - 886 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Early on-treatment viral load and baseline METAVIR score: improved prediction of sustained virological response in HCV genotype 1 patients

Crawford, D., Dore, G. J., Sievert, W., Cheng, W., Weltman, M. D., McCaughan, G., Rawlinson, W., Marks, P., Yoshihara, M., Rizkalla, B. & Roberts, S. K., 2012, In : Antiviral Therapy. 17, 5, p. 849 - 854 6 p.

Research output: Contribution to journalArticleResearchpeer-review